BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20/08/2024

FDA Clears PENNSAID Topical Solution 2% for Sale

The US Food and Drug Administration has ruled that PENNSAID (diclofenac sodium) Topical Solution 2% was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain on the market.

Source: Federal Register — Food and Drug AdministrationOpen original release →